Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...

Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences ...

The U.S. Food and Drug Administration approved a once-daily pill version of Novo Nordisk’s blockbuster GLP-1 weight loss drug Wegovy. The FDA made the decision Dec. 22. The starting dose of 1.5 ...

The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of Ozempic and Wegovy, ...

The agency cited 2 deaths and a case of suicidal ideation among incidents that were not submitted within required timeframes ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

(The Hill) – The Food and Drug Administration (FDA) has approved Novo Nordisk’s oral version of the Wegovy weight-loss pill, the first such supplement approved for use. Novo Nordisk said in a Tuesday ...

Savannah Chrisley’s prescription weight loss website was flagged by the FDA over potentially misleading claims about GLP-1s.

(Competitive Insight/Unsplash) While GLP-1 drugs such as Wegovy and Ozempic are now being broadly championed and widely used, ...

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.

March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making ...